Lisheng Wang

4.4k total citations · 2 hit papers
87 papers, 2.9k citations indexed

About

Lisheng Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lisheng Wang has authored 87 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 21 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Lisheng Wang's work include Extracellular vesicles in disease (17 papers), MicroRNA in disease regulation (11 papers) and Gastric Cancer Management and Outcomes (10 papers). Lisheng Wang is often cited by papers focused on Extracellular vesicles in disease (17 papers), MicroRNA in disease regulation (11 papers) and Gastric Cancer Management and Outcomes (10 papers). Lisheng Wang collaborates with scholars based in China, Hong Kong and Canada. Lisheng Wang's co-authors include Yiru Wang, Qingquan Liu, Dawei Ye, Jun Yao, Defeng Li, Yujie Liang, Haoming Xu, Meifeng Yang, Cheng‐mei Tian and Min‐zheng Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Lisheng Wang

81 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

2020 801 citations Lisheng Wang et al. profile →
Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion

2023 102 citations Min‐zheng Zhu, Haoming Xu et al. Journal of Nanobiotechnology profile →

Peers

Lisheng Wang

ONCOL

IMMUN

Collet Dandara South Africa

Peipei Song China

Hongbo Chen China

Jing Cai China

Fang Yu United States

Desheng Hu China

Tiantian Liu China

Wei Pan China

Li Su China

William E. Brady United States

Collet Dandara South Africa

Lisheng Wang

1.2k ×1.0

612 ×1.2

471 ×1.2

895 ×2.5

ONCOL

304 ×1.0

IMMUN

Citations per year, relative to Lisheng Wang Lisheng Wang (= 1×) peers Collet Dandara

Countries citing papers authored by Lisheng Wang

Since Specialization

Citations

This map shows the geographic impact of Lisheng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisheng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisheng Wang more than expected).

Fields of papers citing papers by Lisheng Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisheng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisheng Wang. The network helps show where Lisheng Wang may publish in the future.

Co-authorship network of co-authors of Lisheng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lisheng Wang. A scholar is included among the top collaborators of Lisheng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisheng Wang. Lisheng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Yanqing, Hao Zhang, Huiyan Sun, et al.. (2025). Mitochondrial uncoupler BAM15 enhances the function of CD7CAR-TCD7− cells and reduces the release of cytokines for the therapy of T-cell malignancies. International Immunopharmacology. 155. 114577–114577.

Tian, Cheng‐mei, Meifeng Yang, Kong Chen, et al.. (2025). Microbiome–Gut–Brain Axis: Implications for the Links Between Inflammatory Bowel Disease and Neuropsychiatric Disorders. Journal of Inflammation Research. Volume 18. 13183–13212. 1 indexed citations

Chen, Kong, et al.. (2024). Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy. Journal of Inflammation Research. Volume 17. 5389–5413. 20 indexed citations

Hu, Peng, Cheng‐mei Tian, Kong Chen, et al.. (2024). Dissecting Innate and Adaptive Immunity in Inflammatory Bowel Disease: Immune Compartmentalization, Microbiota Crosstalk, and Emerging Therapies. Journal of Inflammation Research. Volume 17. 9987–10014. 4 indexed citations

Xu, Haoming, Jing Xu, Min‐zheng Zhu, et al.. (2023). Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives. Molecular Therapy — Oncolytics. 30. 193–215. 4 indexed citations

Tian, Cheng‐mei, Meifeng Yang, Haoming Xu, et al.. (2023). Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases. Stem Cells International. 2023. 1–16. 24 indexed citations

Li, Defeng, Qi Tang, Meifeng Yang, et al.. (2023). Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease. Nanoscale Advances. 5(14). 3575–3588. 29 indexed citations

Tian, Cheng‐mei, Meifeng Yang, Haoming Xu, et al.. (2023). Emerging role of bacterial outer membrane vesicle in gastrointestinal tract. Gut Pathogens. 15(1). 20–20. 37 indexed citations

Zhu, Min‐zheng, Haoming Xu, Yujie Liang, et al.. (2023). Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion. Journal of Nanobiotechnology. 21(1). 309–309. 102 indexed citations breakdown →

10.

Lu, Quan, Meifeng Yang, Yujie Liang, et al.. (2022). Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics. SHILAP Revista de lepidopterología. 114 indexed citations

11.

Xu, Haoming, Jing Xu, Meifeng Yang, et al.. (2022). Epigenetic DNA methylation of Zbtb7b regulates the population of double-positive CD4+CD8+ T cells in ulcerative colitis. Journal of Translational Medicine. 20(1). 289–289. 11 indexed citations

12.

Li, Defeng, Meifeng Yang, Haoming Xu, et al.. (2022). Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. Journal of Materials Chemistry B. 10(31). 5853–5872. 65 indexed citations

13.

Xiong, Feng, Wei Cheng, Su Luo, et al.. (2022). Impact of an Abdominal Compression Bandage on the Completion of Colonoscopy for Obese Adults: A Prospective Randomized Controlled Trial. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–8. 7 indexed citations

14.

Guo, Liliangzi, Yuting Li, Jun Yao, et al.. (2021). Dairy Consumption and Risk of Conventional and Serrated Precursors of Colorectal Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Journal of Oncology. 2021. 1–15. 11 indexed citations

15.

Muradia, Gauri, Christian Luebbert, Michael Johnston, et al.. (2021). Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell. Stem Cell Research & Therapy. 12(1). 127–127. 82 indexed citations

16.

Yang, Meifeng, Feng Xiong, Wei Cheng, et al.. (2021). Optimal Timing of Simethicone Supplement for Bowel Preparation: A Prospective Randomized Controlled Trial. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 4032285–4032285. 9 indexed citations

17.

Shi, Kang, et al.. (2018). Fluctuation and reform: A tale of two RMB markets. China Economic Review. 53. 30–52. 23 indexed citations

18.

Yu, Zu‐Yin, Limei Wang, Xing Shen, et al.. (2016). Natural Product Vibsanin A Induces Differentiation of Myeloid Leukemia Cells through PKC Activation. Cancer Research. 76(9). 2698–2709. 30 indexed citations

19.

Mohib, Kanishka, et al.. (2012). Embryonic Stem Cell-Derived Factors Inhibit T Effector Activation and Induce T Regulatory Cells by Suppressing PKC-θ Activation. PLoS ONE. 7(3). e32420–e32420. 9 indexed citations

20.

Wang, Lisheng. (2009). Forecast of Carbon Dioxide Emission Arising from Fossil Energy Consumption in China. Water Resources and Power. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact